Premium
Letter: detection of infliximab levels and anti‐infliximab antibodies – comparison of three different assays; authors’ reply
Author(s) -
Buurman D. J.,
Vande Casteele N.,
Sturkenboom M. G. G.,
Kleibeuker J. H.,
Vermeire S.,
Kleij D.,
Rispens T.,
Gils A.,
Dijkstra G.
Publication year - 2013
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12128
Subject(s) - medicine , infliximab , suspect , protocol (science) , regret , test (biology) , medical physics , immunology , pathology , statistics , psychology , mathematics , alternative medicine , paleontology , tumor necrosis factor alpha , criminology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom